cagrisema phase 3 results 2025 semaglutide cagrilintide obesity Cagrilintide–semaglutide (CagriSema) versus or in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, study cagrisema phase 3 results 2025

10.1016/j.acthis.2010.01.001 [DOI] [PubMed] [Google Scholar] Santulli P., Even M., Chouzenoux S., Millischer A.-E., Borghese B., de Ziegler D., et al

Branded GLP-1 therapy often runs several hundred to over a thousand dollars a month without coverage, and insurance approval specifically for weight management (as opposed to diabetes) can be difficult to secure

Effects of Combining Weed with Ozempic Cannabis and its active compounds can affect how other medications work in your body, and this includes the diabetes medication Ozempic ( semaglutide ), a GLP-1 agonist

Do Not Double Down: Do not take any more medication until your doctor specifically tells you it is safe to resume your schedule

This could contribute to the mentioned side effects of brain fog, mood swings, and even faster cognitive decline, which are some of the very issues we hope to prevent

The benefit of weight loss does not justify deteriorating mental health